In today's rapidly developing biopharmaceuticals, the choice of excipients directly affects the stability, safety and patient experience of drugs. Sorbitol (D-sorbitol), as a multifunctional sugar alcohol, has occupied an irreplaceable position in the field of biopharmaceuticals. This article will provide an in-depth analysis of the physical and chemical properties of sorbitol, its core application scenarios in biopharmaceuticals, regulatory compliance requirements, and global market trends, providing a reference for pharmaceutical R&D and procurement professionals.

1. Physicochemical properties and pharmaceutical-grade specifications of sorbitol

Sorbitol (molecular formula: C₆H₁₄O₆, molecular weight: 182.17 g/mol) is a hexacarbon sugar alcohol prepared by the hydroreduction of glucose. Its core physical and chemical properties include:

· Highly water-soluble：The solubility at 25°C is approximately 235 g/100 mL, making it suitable for liquid preparations

· Low sweetness and low calories：The sweetness is about 60% of that of sucrose, and the calories are about 2.4 kcal/g

· Chemical inertness：Stable in the neutral to slightly acidic pH range without Maillard reactions

· Moderate hygroscopicity：Helps maintain the water balance of solid dosage forms

· The glass transition temperature (Tg') is about -43°C：Key parameters in the lyophilization process

Pharmaceutical-grade sorbitol must meet several authoritative standards：USP、EP、JP，There are strict regulations on purity (≥97.0%), heavy metal content, microbial limits, etc.

2. Five core applications of sorbitol in biopharmaceuticals

1. Cryoprotectant for protein and antibody drugs

Lyophilization is the mainstream preservation method for protein biopharmaceuticals (monoclonal antibodies, recombinant proteins, vaccines). Sorbitol, as a lyophilized protectant, works through the following mechanisms:

· Water Replacement Theory：During the drying process, the hydroxyl group of sorbitol replaces the water molecule and forms hydrogen bonds with the protein, maintaining the natural conformation of the protein

· Vitrification effect：When combined with disaccharides (such as trehalose and sucrose), the glass transition temperature of freeze-dried cakes can be controlled to prevent crystallization from damaging the protein structure

Typical application concentrations are 1%–10% (w/v) and are commonly used in lyophilized powder injection formulations for injection.

2. Isotonic regulators and stabilizers for liquid preparations

In injectables, ophthalmic preparations, sorbitol is used to regulate osmolality (isotonic reference value: 308 mOsm/kg). Its advantages are:

· Compared to sodium chloride, it is more friendly to the conformational stability of some proteins

· It can reduce the surface tension-related aggregation tendency of proteins

· It can reduce the surface tension-related aggregation tendency of proteins

3. Stable matrix for vaccine preparations

Sorbitol is widely used in the stable formulation of live attenuated vaccines (e.g., measles, rubella, mumps combination vaccine MMR) and its effects include:

· Delay viral titer loss in cold chain storage at 2–8°C

· Acts as a lyophilized excipient to protect the lipid envelope integrity of viral particles

· It cooperates with gelatin, lactose and other excipients to build a multiple protection system

4. Functional excipients for oral solid dosages

In tablets and capsules, sorbitol plays the following roles：

Sweeteners and flavor correctorsDirect tablet adhesive

5. Emerging applications of cell therapy and gene therapy

5. Emerging applications of cell therapy and gene therapy

· mRNA-LNPPreparations：With the rapid development of CAR-T cell therapies, mRNA vaccines, and adeno-associated virus (AAV) gene vectors, sorbitol has gained traction in the following areas:

· AAV Carrier storage：Cell culture medium

· Cell culture medium：As an osmoregulatory ingredient in some media formulations

3. Key points of regulatory compliance and quality control

Regulatory classification

Regulatory classificationsorbitol

· FDA IIG Database: Contains usage limits for multiple routes of administration

· FDA IIG Database: Contains usage limits for multiple routes of administration

· EMA Excipient Guidelines: Requires the provision of a safety data package for excipients at the time of formulation submission

Key quality attributes（CQA）

In GMP manufacturing, pharmaceutical-grade sorbitol must control the following CQAs:

· content（97.0%–102.0%）

· Reducing sugar limits（≤0.2%）

· Reducing sugar limits（≤1.5%，Karl Fischer法）

· Iron, heavy metals（≤5 ppm）

· Clarity and color

· Microbial limits and bacterial endotoxins (injection grade)

CMC Documentation requirements

In a new drug application (NDA/BLA) or generic drug application (ANDA), the excipient-related CMC documents should include: supplier qualifications, pharmacopoeia certificate of conformity, batch analysis report (CoA), and excipient safety information form (ESID) if necessary.

4. Global market analysis and supply chain trends

Market size

The global pharmaceutical sorbitol market has grown steadily in recent years, driven by factors such as:

· Global expansion of biologics and vaccine capacity

· Increasing demand for pediatric and geriatric oral formulations

· Large-scale commercialization of mRNA vaccine platforms

Major manufacturers include France, USA, USA, SPI Pharma, Huakang Co., Ltd. and Zhejiang Huakang Pharmaceutical Co., Ltd. in China.

Supply chain risks and countermeasures

Logistics disruption

5. Precautions in formula development

Compatibility with other excipients

· Sorbitol is compatible with povidone (PVP) and hypromellose (HPMC)

· Avoid direct contact with strong oxidants (such as periodate), which may trigger oxidative degradation

· Under high temperature and humidity conditions, there is a potential risk of condensation reaction with primary amines API, which needs to be verified by stability studies

Optimization suggestions for lyophilization process

· Tg' is about -43°C, and the lyophilized primary drying temperature must be lower than this temperature (usually set to -45°C to -50°C)

· It is recommended to compound with sucrose (Tg' ≈-32°C) to improve the overall formulation of Tg' and optimize the lyophilization efficiency

· The annealing step helps improve the consistency of the cake appearance

6. Future prospects

As the biopharmaceutical industry evolves towards high-concentration protein preparations, subcutaneous injection preparations (SC), and continuous manufacturing, the application scenarios of sorbitol will be further expanded. In particular:

· Viscosity regulation of high-concentration monoclonal antibodies (≥ 100 mg/mL).

· Optimized fit of prefilled syringes with self-injection devices

· Cold chain protection systems for cell and gene therapy products

sorbitolWith its proven safety data, extensive regulatory recognition, and versatile properties, it will continue to play a key role in the field of biopharmaceutical excipients.